RB

Ravindrakumar Bhailalbhai Patel

Active Director Whole-Time Director DIN 11510344
DIN 11510344 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ravindrakumar Bhailalbhai Patel

Data last updated:

Ravindrakumar Bhailalbhai Patel is a Whole-Time Director at Aarvi Meditech Private Limited (since 2026).

DIN 11510344
Primary Designation Whole-Time Director
First Appointment 28 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aarvi Meditech Private Limited U32503GJ2026PTC172748
Whole-Time Director28 Jan 20262026Active

Board colleagues of Ravindrakumar Bhailalbhai Patel

NameDINCompanyDesignation
Gaurav Kanaiyalal Patel07969049Aarvi Meditech Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Aarvi Meditech Private Limited
Premium access

Shareholding and investment profile for Ravindrakumar Bhailalbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindrakumar Bhailalbhai Patel

Ravindrakumar Bhailalbhai Patel currently holds 1 directorship: Aarvi Meditech Private Limited (Whole-Time Director, since 28 Jan 2026).

Ravindrakumar Bhailalbhai Patel was first appointed on 28 Jan 2026 as Whole-Time Director at Aarvi Meditech Private Limited.

The current boards of Ravindrakumar Bhailalbhai Patel's companies include Gaurav Kanaiyalal Patel (Aarvi Meditech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available